Krystal Biotech, Inc.
SEC CIK 1711279 · KRYS · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Krishnan Krish S | Director · President and CEO | filed 2017 - 2026 |
| Krishnan Suma | Director · President, R&D | filed 2017 - 2026 |
| Janney Daniel | Director | filed 2017 - 2026 |
| Rossi Dino A | Director | filed 2017 - 2026 |
| Gangolli Julian S | Director | filed 2019 - 2025 |
| Mason Christopher | Director | filed 2021 - 2025 |
| Sutherland Everett Rand | Director | filed 2022 - 2025 |
| Mazzacco Catherine | Director | filed 2023 - 2025 |
| Marantz Jing L. | Director · Chief Business Officer | filed 2021 - 2022 |
| Norby R Douglas | Director | filed 2017 - 2018 |
| Ganorkar Kirti | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Thomas John Charles | EVP, General Counsel | filed 2026 - 2026 |
| Goux Laurent Louis Jean | EVP, Head of International | filed 2026 - 2026 |
| Romano Kathryn | Chief Accounting Officer | filed 2020 - 2026 |
| Orth Andrew C. | Chief Commercial Officer | filed 2021 - 2023 |
| Lee Jennifer Kayden | Chief Commercial Officer | filed 2020 - 2020 |
| Riley Antony A | Chief Financial Officer | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.